Lau Cia-Hin, Tin Chung, Suh Yousin
Department of Biomedical Engineering, Academic 1, 83 Tat Chee Avenue, City University of Hong Kong, Hong Kong.
Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, 630 West 168th Street, New York, NY 10032, USA.
Fac Rev. 2020 Dec 4;9:20. doi: 10.12703/r/9-20. eCollection 2020.
The last few years have seen tremendous advances in CRISPR-mediated genome editing. Great efforts have been made to improve the efficiency, specificity, editing window, and targeting scope of CRISPR/Cas9-mediated transgene knock-in and gene correction. In this article, we comprehensively review recent progress in CRISPR-based strategies for targeted transgene knock-in and gene correction in both homology-dependent and homology-independent approaches. We cover homology-directed repair (HDR), synthesis-dependent strand annealing (SDSA), microhomology-mediated end joining (MMEJ), and homology-mediated end joining (HMEJ) pathways for a homology-dependent strategy and alternative DNA repair pathways such as non-homologous end joining (NHEJ), base excision repair (BER), and mismatch repair (MMR) for a homology-independent strategy. We also discuss base editing and prime editing that enable direct conversion of nucleotides in genomic DNA without damaging the DNA or requiring donor DNA. Notably, we illustrate the key mechanisms and design principles for each strategy, providing design guidelines for multiplex, flexible, scarless gene insertion and replacement at high efficiency and specificity. In addition, we highlight next-generation base editors that provide higher editing efficiency, fewer undesired by-products, and broader targeting scope.
在过去几年中,CRISPR介导的基因组编辑取得了巨大进展。人们为提高CRISPR/Cas9介导的转基因敲入和基因校正的效率、特异性、编辑窗口和靶向范围付出了巨大努力。在本文中,我们全面回顾了基于CRISPR的靶向转基因敲入和基因校正策略在同源依赖性和非同源依赖性方法方面的最新进展。我们涵盖了同源依赖性策略中的同源定向修复(HDR)、合成依赖性链退火(SDSA)、微同源性介导的末端连接(MMEJ)和同源性介导的末端连接(HMEJ)途径,以及非同源依赖性策略中的替代DNA修复途径,如非同源末端连接(NHEJ)、碱基切除修复(BER)和错配修复(MMR)。我们还讨论了碱基编辑和引导编辑,它们能够直接转化基因组DNA中的核苷酸,而不会损坏DNA或需要供体DNA。值得注意的是,我们阐述了每种策略的关键机制和设计原则,为高效、特异性的多重、灵活、无痕基因插入和替换提供了设计指南。此外,我们重点介绍了下一代碱基编辑器,它们具有更高的编辑效率、更少的不良副产物和更广泛的靶向范围。